Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
François Ghiringhelli(Inserm), Cédric Menard(Inserm), Pierre E. Puig(Inserm), Sylvain Ladoire, S. Roux(Institut Gustave Roussy), François Martin(Inserm), Éric Solary(Inserm), Axel Le Cesne(Institut Gustave Roussy), Laurence Zitvogel(Institut Gustave Roussy), Bruno Chauffert(Inserm)
Cited by 1,227Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis